HHS to allow sale of unapproved peptides under review
The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the "Make America Healthy Again" (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion...
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
